The bispecific antibody ATOR-1015 [CTLA-4xOX40] induced CD8+ T cell activation and Treg depletion in several syngeneic tumor models including a PDAC model, thereby resulting in a tumor-specific and long-term immunological memory. Here, CD8A is linked to neoplasm.